ABBV-CLS-484 Clinical Trials (2026): 2 Studies for Advanced Solid Tumor Cancer
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
2 ABBV-CLS-484 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Advanced Solid Tumor Cancer) and 248 total planned enrollment. 1 ABBV-CLS-484 clinical trial is actively recruiting at 13 U.S. sites across 10 states. Most recent activity: NCT04777994 (Oct 2026).
Where to Participate: All ABBV-CLS-484 Trial Sites in the U.S. (13 sites across 10 states)
Every actively recruiting ABBV-CLS-484trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AZ | University of Arizona Cancer Center - Tucson /ID# 262698 | Tucson85724 | NCT04777994 | Map |
| CT | Yale University School of Medicine /ID# 225707 | New Haven06510 | NCT04777994 | Map |
| MD | Johns Hopkins Hospital /ID# 254056 | Baltimore21287 | NCT04777994 | Map |
| MA | Beth Israel Deaconess Medical Center /ID# 252009 | Boston02215-5400 | NCT04777994 | Map |
| MA | Dana-Farber Cancer Institute /ID# 249642 | Boston02215 | NCT04777994 | Map |
| MI | University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010 | Ann Arbor48109 | NCT04777994 | Map |
| NY | NYU Laura and Isaac Perlmutter Cancer Center - 34th Street /ID# 257869 | New York10016 | NCT04777994 | Map |
| NC | Duke Cancer Center /ID# 251975 | Durham27710 | NCT04777994 | Map |
| PA | Perelman Center for Advanced Medicine /ID# 250188 | Philadelphia19104 | NCT04777994 | Map |
| PA | UPMC Hillman Cancer Ctr /ID# 225706 | Pittsburgh15232 | NCT04777994 | Map |
| RI | Lifespan Cancer Institute at Rhode Island Hospital /ID# 225705 | Providence02903-4923 | NCT04777994 | Map |
| TX | University of Texas Southwestern Medical Center /ID# 251974 | Dallas75390-7208 | NCT04777994 | Map |
| TX | University of Texas MD Anderson Cancer Center /ID# 252004 | Houston77030 | NCT04777994 | Map |
ABBV-CLS-484 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | available | Total |
|---|---|---|---|
| P1 | 1 | 1 | |
| N/A | 1 | 1 |
Recruiting ABBV-CLS-484 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT04777994 | Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors | P1 | Advanced Solid Tumor Cancer | 248 | Mar 2021 |
All ABBV-CLS-484 trials (2)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT04777994 | Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors | P1 | recruiting | 248 | Calico Life Sciences LLC | Mar 2021 | |
| NCT06188975 | Expanded Access to ABBV-CLS-484 | — | available | 0 | Calico Life Sciences LLC | — |
ABBV-CLS-484 clinical trials: frequently asked questions
- How many ABBV-CLS-484 clinical trials are there?
- 2 ABBV-CLS-484 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are ABBV-CLS-484 clinical trials recruiting in 2026?
- Yes — 1 ABBV-CLS-484 trial is actively recruiting in 2026, with 13 U.S. sites across 10 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is ABBV-CLS-484 being studied for?
- ABBV-CLS-484 is being studied for Advanced Solid Tumor Cancer. The trials are grouped by indication on this page.
- What phase is ABBV-CLS-484 in?
- ABBV-CLS-484 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors ABBV-CLS-484 clinical trials?
- The lead sponsor across the most ABBV-CLS-484 trials is Calico Life Sciences LLC. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming ABBV-CLS-484as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: